Financhill
Back

Cellectis SA Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
43

CLLS
Cellectis SA

Last Price:
2.21
Seasonality Move:
12.21%
Sell
35

ALNY
Alnylam Pharmaceuticals

Last Price:
275.08
Seasonality Move:
4.48%
Sell
43
Cellectis SA (CLLS) is a Sell

Is Cellectis SA a Buy, Sell or Hold?

  • The current Cellectis SA [CLLS] share price is $2.18. The Score for CLLS is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • CLLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $274.91. The Score for ALNY is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CLLS Stock Price Chart

What is Cellectis SA's stock price today?

  • The Cellectis SA share price today is $2.18
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLLS is experiencing slight selling pressure.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $274.91
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing slight buying pressure.

CLLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 45.02 Sell
Chaikin Money Flow: -1027 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.22 - 2.36) Sell
Bollinger Bands (100): (1.98 - 2.68) Sell

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.58 Buy
Relative Strength Index (14 RSI): 58.54 Buy
Chaikin Money Flow: 227264 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (257.28 - 277.8) Buy
Bollinger Bands (100): (173.47 - 275.75) Buy

CLLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.23 Sell
20-day SMA: 2.27 Sell
50-day SMA: 2.21 Sell
200-day SMA: 2.57 Sell
8-day EMA: 2.22 Sell
20-day EMA: 2.25 Sell
50-day EMA: 2.25 Sell
200-day EMA: 2.39 Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 273.53 Buy
20-day SMA: 264.94 Buy
50-day SMA: 262.48 Buy
200-day SMA: 194.67 Buy
8-day EMA: 272.54 Buy
20-day EMA: 269.21 Buy
50-day EMA: 257.72 Buy
200-day EMA: 211.82 Buy

Cellectis SA Earnings Growth & CLLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.76 per share, and a decrease next year of $0.35 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.57 per share, an increase next quarter of $0.47 per share, an increase this year of $1.33 per share, and an increase next year of $0.70 per share.

Cellectis SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):